NY State Senate Bill S7102

Archive: Last Bill Status - Passed Senate

Introduced
In Committee
On Floor Calendar
- Passed Senate
- Passed Assembly
Delivered to Governor
Signed/Vetoed by Governor

Your Voice

Please enter your contact information

First Name *

Last Name *

Email Address *

A valid email address is required.

Home address search or enter your address manually *

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Leave this field blank

Actions

view actions (8)

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Feb 04, 2020	referred to higher education delivered to assembly passed senate
Jan 21, 2020	advanced to third reading amended 7102a
Jan 15, 2020	2nd report cal.
Jan 14, 2020	1st report cal.173
Jan 08, 2020	referred to health

Votes

view votes

Feb 4, 2020 - floor Vote

S7102A

floor

Aye

Nay

Absent

Excused

Abstained

Jan 14, 2020 - Health committee Vote

S7102

committee

Aye

Nay

Aye with Reservations

Absent

Excused

Abstained

Bill Amendments

Original

A (Active)

Original

A (Active)

Co-Sponsors

S7102 - Details

Current Committee:: Assembly Higher Education
Law Section:: Public Health Law
Laws Affected:: Amd §3309-a, Pub Health L
Versions Introduced in Other Legislative Sessions:: 2021-2022: S591, S8092
2023-2024: S5066

S7102 - Summary

Relates to the training requirements for prescribers of certain pain medications.

S7102 - Sponsor Memo

 
BILL NUMBER: S7102

SPONSOR: BENJAMIN
 
TITLE OF BILL:

An act to amend the public health law, in relation to training for pres-
cribers of certain pain medications

 
PURPOSE:

Updates training for prescribers of controlled substances to include
best practices for patient centered care, social determents of health,
and co-occurring disorders

 
SUMMARY OF PROVISIONS;

Section 1 of the bill amends paragraph c of subdivision 3 of Section
3309-a of the Public Health Law to require Commissioner of Health, in
consultation with the State Education Department, and the Office of
Addiction Services and Supports to update the course work or training in
pain management, palliative care, and addiction for medical profes-

sionals that prescribe controlled substances to include best practices
for providing patient centered care in consideration of social determi-
nants of health and co-occurring disorders.

Section 2 of the bill amends paragraph f of subdivision 3 of Section
3309-a of the Public Health law to expand the required course work or
training for licensed medical professionals that prescribe controlled
substances to include techniques that will reduce the likelihood of
overdose and the spread of blood-borne diseases by those who use drugs,
medications used for the treatment of addiction, including information
about becoming a buprenorphine prescriber.

Section 3 of the bill includes the effective date.

 
JUSTIFICATION:

Under current law, every licensed medical professional that holds a
federal controlled substance registration from the Drug Enforcement
Agency, the Justice Department, or any medical resident who is prescrib-
ing for a facility, must take a three hours of course work during each
three year registration period on pain management, palliative care, and
addiction.

This training has contributed significantly to reductions in the over-
prescribing of opioids in New York. However, as the overdose epidemic
has progressed and as prescribing practices have evolved, new issues
have emerged, as have new strategies for addressing these issues. For
example, even as overprescribing decreased, overdoses and deaths contin-
ued to rise as a result of addictions to non-prescribed opioids and
other controlled substances. Medical professionals can play an essential
role in identifying addiction early and intervening before it worsens.

Separately, because of concerns about the consequences of doctors being
overly-aggressive in weaning patients from prescribed opioids, in April
2019, the Federal Centers for Disease Control and Prevention released an
advisory against misapplication of their 2016 Guideline for Prescribing
Opioids for Chronic Pain.

Additionally, medication assisted treatment is considered the gold stan-
dard for treating patients with opioid use disorder. However, a lack of
prescribers has limited access to these medications. This training
provides an important opportunity to educate prescribers about the use
of medications, including buprenorphine, in addressing opioid use disor-
ders, and about the training and waiver requirements that practitioners
must complete in order to prescribe buprenorphine to patients with an
opioid use disorder. Providing information on how to become a prescriber
of buprenorphine may encourage more medical professionals to obtain the
needed waiver, thereby increasing patient access to this lifesaving
intervention.

Ensuring that practitioners are aware of current concerns and are
educated about the most up-to-date best practices in pain management,
palliative care and addiction will maximize the impact of this important
training, thereby improving patient health and reducing unnecessary
addiction, pain and mortality.

 
LEGISLATIVE HISTORY:

New Bill

 
FISCAL IMPLICATIONS:

None to the state.

 
EFFECTIVE LAW:

120th day

S7102 - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  7102

                            I N  S E N A T E

                               (PREFILED)

                             January 8, 2020
                               ___________

Introduced  by Sen. BENJAMIN -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to training for pres-
  cribers of certain pain medications

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Paragraph  (c)  of subdivision 3 of section 3309-a of the
public health law, as added by section 1 of part A of chapter 71 of  the
laws of 2016, is amended to read as follows:
  (c) The commissioner, in consultation with the department of education
and  the  office  of [alcoholism and substance abuse] ADDICTION services
AND SUPPORTS, shall establish standards and review  and  approve  course
work  or training in pain management, palliative care, and addiction AND
UPDATE SUCH STANDARDS AND APPROVALS AS NECESSARY ACCORDING TO BEST PRAC-
TICES FOR PROVIDING PATIENT CENTERED  CARE  WITH  THE  CONSIDERATION  OF
SOCIAL  DETERMINANTS  OF  HEALTH  AND  CO-OCCURING  DISORDERS  and shall
publish information related to such standards, course work  or  training
on the department's website.
  §  2.  Paragraph  (f) of subdivision 3 of section 3309-a of the public
health law, as added by section 1 of part A of chapter 71 of the laws of
2016, is amended to read as follows:
  (f) Course work or training shall include,  but  not  be  limited  to:
state  and  federal  requirements for prescribing controlled substances;
pain management; appropriate prescribing; managing acute  pain;  pallia-
tive  medicine; prevention, screening and signs of [addiction] SUBSTANCE
USE DISORDER; responses to abuse and  addiction;  TECHNIQUES  THAT  WILL
REDUCE THE LIKELIHOOD OF OVERDOSE AND THE SPREAD OF BLOOD-BORNE DISEASES
BY THOSE WHO USE DRUGS; MEDICATIONS USED FOR THE TREATMENT OF ADDICTION,
INCLUDING INFORMATION ABOUT BECOMING A BUPRENORPHINE PRESCRIBER; and end
of life care.
  § 3. This act shall take effect on the one hundred twentieth day after
it  shall have become a law. Effective immediately, the addition, amend-
ment and/or repeal of any rule or regulation necessary for the implemen-

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD14616-01-9

S. 7102                             2

tation of this act on its effective date are authorized to be  made  and
completed  by  the  department  of health in consultation with the state
education department and the office of addiction services  and  supports
on or before such effective date.

Co-Sponsors

S7102A (ACTIVE) - Details

Current Committee:: Assembly Higher Education
Law Section:: Public Health Law
Laws Affected:: Amd §3309-a, Pub Health L
Versions Introduced in Other Legislative Sessions:: 2021-2022: S591, S8092
2023-2024: S5066

S7102A (ACTIVE) - Summary

Relates to the training requirements for prescribers of certain pain medications.

S7102A (ACTIVE) - Sponsor Memo

 
BILL NUMBER: S7102A

SPONSOR: BENJAMIN
 
TITLE OF BILL:

An act to amend the public health law, in relation to training for pres-
cribers of certain pain medications

 
PURPOSE:

Updates training for prescribers of controlled substances to include
best practices for patient centered care, social determents of health,
and co-occurring disorders

 
SUMMARY OF PROVISIONS:;

Section 1 of the bill amends paragraph c of subdivision 3 of Section
3309-a of the Public Health Law to require Commissioner of Health, in
consultation with the State Education Department, and the Office of
Addiction Services and Supports to update the course work or training in
pain management, palliative care, and addiction for medical profes-

sionals that prescribe controlled substances to include best practices
for providing patient centered care in consideration of social determi-
nants of health and co-occurring disorders.

Section 2 of the bill amends paragraph f of subdivision 3 of Section
3309-a of the Public Health law to expand the required course work or
training for licensed medical professionals that prescribe controlled
substances to include techniques that will reduce the likelihood of
overdose and other harms related to the use of controlled substances
and, medications used for the treatment of addiction, including informa-
tion about becoming a buprenorphine prescriber. These new training
requirements will take effect for those licensed healthcare providers
that are due to re-register after July 1, 2021.

Section 3 of the bill includes the effective date.

 
JUSTIFICATION:

Under current law, every licensed medical professional that holds a
federal controlled substance registration from the Drug Enforcement
Agency, the Justice Department, or any medical resident who is prescrib-
ing for a facility, must take a three hours of course work during each
three year registration period on pain management, palliative care, and
addiction.

This training has contributed significantly to reductions in the over-
prescribing of opioids in New York. However, as the overdose epidemic
has progressed and as prescribing practices have evolved, new issues
have emerged, as have new strategies for addressing these issues. For
example, even as overprescribing decreased, overdoses and deaths contin-
ued to rise as a result of addictions to non-prescribed opioids and
other controlled substances. Medical professionals can play an essential
role in identifying addiction early and, intervening before it worsens.

Separately, because of concerns about the consequences of doctors being
overly-aggressive in weaning patients from prescribed opioids, in April
2019, the Federal Centers for Disease Control and Prevention released an
advisory against misapplication of their 2016 Guideline for Prescribing
Opioids for Chronic Pain.  Additionally, medication assisted treatment
is considered the gold standard for treating patients with opioid use
disorder. However, a lack of prescribers has limited access to these
medications. This training provides an important opportunity to educate
prescribers about the use of medications, including buprenorphine, in
addressing opioid use disorders, and about the training and waiver
requirements that practitioners must complete in order to prescribe
buprenorphine to patients with an opioid use disorder. Providing infor-
mation on how to become a prescriber of buprenorphine may encourage more
medical professionals to obtain the needed waiver, thereby increasing
patient access to this lifesaving intervention.

Ensuring that practitioners are aware of current concerns and are
educated about the most up-to-date best practices in pain management,
palliative care and addiction will maximize the impact of this important
training, thereby improving patient health and reducing unnecessary
addiction, pain and mortality.

 
LEGISLATIVE HISTORY:

New Bill

 
FISCAL IMPLICATIONS:

None to the state.

 
EFFECTIVE LAW:

120th day

S7102A (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 7102--A
    Cal. No. 173

                            I N  S E N A T E

                               (PREFILED)

                             January 8, 2020
                               ___________

Introduced by Sens. BENJAMIN, METZGER -- read twice and ordered printed,
  and  when  printed  to  be  committed  to  the  Committee on Health --
  reported favorably from said committee, ordered to  first  and  second
  report,  amended  on second report, ordered to a third reading, and to
  be reprinted as amended, retaining its place in  the  order  of  third
  reading

AN ACT to amend the public health law, in relation to training for pres-
  cribers of certain pain medications

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Paragraph (c) of subdivision 3 of  section  3309-a  of  the
public  health law, as added by section 1 of part A of chapter 71 of the
laws of 2016, is amended to read as follows:
  (c) The commissioner, in consultation with the department of education
and the office of [alcoholism and substance  abuse]  ADDICTION  services
AND  SUPPORTS,  shall  establish standards and review and approve course
work or training in pain management, palliative care, and addiction  AND
UPDATE SUCH STANDARDS AND APPROVALS AS NECESSARY ACCORDING TO BEST PRAC-
TICES  FOR  PROVIDING  PATIENT  CENTERED  CARE WITH THE CONSIDERATION OF
SOCIAL DETERMINANTS  OF  HEALTH  AND  CO-OCCURING  DISORDERS  and  shall
publish  information  related to such standards, course work or training
on the department's website.
  § 2. Paragraph (f) of subdivision 3 of section 3309-a  of  the  public
health law, as added by section 1 of part A of chapter 71 of the laws of
2016, is amended to read as follows:
  (f)  Course  work  or  training  shall include, but not be limited to:
state and federal requirements for  prescribing  controlled  substances;
pain  management;  appropriate prescribing; managing acute pain; pallia-
tive medicine; prevention, screening and signs of [addiction]  SUBSTANCE
USE  DISORDER;  responses  to abuse and addiction; and end of life care.
FOR EACH LICENSED PERSON DUE TO RE-REGISTER PURSUANT TO THIS SUBDIVISION
AFTER JULY FIRST, TWO THOUSAND TWENTY-ONE, SUCH COURSE WORK OR  TRAINING
SHALL  ALSO  INCLUDE TECHNIQUES THAT WILL REDUCE THE LIKELIHOOD OF OVER-

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD14616-03-0

S. 7102--A                          2

DOSE AND OTHER HARMS RELATED TO THE USE  OF  CONTROLLED  SUBSTANCES  AND
MEDICATIONS  USED  FOR THE TREATMENT OF ADDICTION, INCLUDING INFORMATION
ABOUT BECOMING A BUPRENORPHINE PRESCRIBER.
  § 3. This act shall take effect on the one hundred twentieth day after
it  shall have become a law. Effective immediately, the addition, amend-
ment and/or repeal of any rule or regulation necessary for the implemen-
tation of this act on its effective date are authorized to be  made  and
completed  by  the  department  of health in consultation with the state
education department and the office of addiction services  and  supports
on or before such effective date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

The New York State Senate

senate Bill S7102

Sponsored By

Archive: Last Bill Status - Passed Senate

Your Voice

Actions

Votes

Feb 4, 2020 - floor Vote

Floor Vote: Feb 4, 2020

Jan 14, 2020 - Health committee Vote

Health Committee Vote: Jan 14, 2020

Bill Amendments

Co-Sponsors

S7102 - Details

S7102 - Summary

S7102 - Sponsor Memo

S7102 - Bill Text download pdf

Co-Sponsors

S7102A (ACTIVE) - Details

S7102A (ACTIVE) - Summary

S7102A (ACTIVE) - Sponsor Memo

S7102A (ACTIVE) - Bill Text download pdf

Comments

senate Bill S7102

Share this bill

Sponsored By

Brian A. Benjamin

Archive: Last Bill Status - Passed Senate

Your Voice

Actions

Votes

Feb 4, 2020 - floor Vote

Floor Vote: Feb 4, 2020

Jan 14, 2020 - Health committee Vote

Health Committee Vote: Jan 14, 2020

Bill Amendments

Co-Sponsors

Jen Metzger

S7102 - Details

S7102 - Summary

S7102 - Sponsor Memo

S7102 - Bill Text download pdf

Co-Sponsors

Alessandra Biaggi

Jen Metzger

S7102A (ACTIVE) - Details

S7102A (ACTIVE) - Summary

S7102A (ACTIVE) - Sponsor Memo

S7102A (ACTIVE) - Bill Text download pdf

Comments